{
    "eid": "2-s2.0-85099367130",
    "title": "Exploring of paritaprevir and glecaprevir resistance due to A156T mutation of HCV NS3/4A protease: molecular dynamics simulation study",
    "cover-date": "2022-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Structural Biology",
            "@code": "1315",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Molecular Biology",
            "@code": "1312",
            "@abbrev": "BIOC"
        }
    ],
    "keywords": [
        "A156T",
        "glecaprevir",
        "Hepatitis C virus",
        "molecular dynamics simulation",
        "NS3/4A protease",
        "paritaprevir"
    ],
    "authors": [
        "Thitiya Boonma",
        "Bodee Nutho",
        "Nitchakan Darai",
        "Thanyada Rungrotmongkol",
        "Nadtanet Nunthaboot"
    ],
    "citedby-count": 1,
    "ref-count": 58,
    "ref-list": [
        "Comparative evaluation of total phenols, flavonoids content and antioxidant potential of leaf and fruit extracts of Omani Ziziphus jujuba L",
        "Insights into resistance mechanism of hepatitis C virus nonstructural 3/4A protease mutant to boceprevir using umbrella sampling simulation study",
        "Global prevalence and genotype distribution of hepatitis C virus infection in 2015: A modelling study",
        "Understanding of the drug resistance mechanism of hepatitis C virus NS3/4A to paritaprevir due to D168N/Y mutations: A molecular dynamics simulation perspective",
        "Harmonic dynamics of proteins: Normal modes and fluctuations in bovine pancreatic trypsin inhibitor (vibrational analysis/protein dynamics/temperature factors/thermodynamic properties/frequency spectrum)",
        "Resistance of hepatitis C virus to NS3-4A protease inhibitors: Mechanisms of drug resistance induced by R155Q, A156T, D168A and D168V mutations",
        "Induced-fit binding of the macrocyclic noncovalent inhibitor TMC435 to its HCV NS3/NS4A protease target",
        "Particle mesh Ewald: An N\u00b7log(N) method for Ewald sums in large systems",
        "Treatment of HCV infection with the novel NS3/4A protease inhibitors",
        "The SCC-DFTB method and its application to biological systems",
        "Molecular docking investigation of the binding interactions of macrocyclic inhibitors with HCV NS3 protease and its mutants (R155K, D168A and A156V)",
        "A comparative study of the efficiency of HCV NS3/4A protease drugs against different HCV genotypes using in silico approaches",
        "Oral direct-acting agent therapy for hepatitis c virus infection: A systematic review",
        "Structure-based design of inhibitors of NS3 serine protease of hepatitis C virus",
        "Molecular dynamics study on drug resistance mechanism of HCV NS3/4A protease inhibitor: BI201335",
        "Hepatitis C virus resistance to protease inhibitors",
        "Relative replication capacity and selective advantage profiles of protease inhibitor-resistant hepatitis C virus (HCV) NS3 protease mutants in the HCV genotype 1b replicon system",
        "Discovery of danoprevir (ITMN-191/R7227), a highly selective and potent inhibitor of hepatitis C virus (HCV) NS3/4A protease",
        "Potential energy functions for atomic-level simulations of water and organic and biomolecular systems",
        "Low susceptibility of asunaprevir towards R155K and D168A point mutations in HCV NS3/4A protease: A molecular dynamics simulation",
        "Calculating structures and free energies of complex molecules: Combining molecular mechanics and continuum models",
        "Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1-6 without cirrhosis",
        "ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB",
        "Molecular mechanism of resistance in a clinically significant double-mutant variant of HCV NS3/4A protease",
        "Hepatitis C virus NS3/4A protease inhibitors incorporating flexible P2 quinoxalines target drug resistant viral variants",
        "Hepatitis C virus NS3/4a protease inhibitors",
        "Effect of D168V mutation in NS3/4A HCV protease on susceptibilities of faldaprevir and danoprevir",
        "Key binding and susceptibility of NS3/4A serine protease inhibitors against hepatitis C virus",
        "Glecaprevir/pibrentasvir for the treatment of chronic hepatitis C virus infection",
        "MMPBSA.py: An efficient program for end-state free energy calculations",
        "Assessing the performance of MM/PBSA, MM/GBSA, and QM-MM/GBSA approaches on protein/carbohydrate complexes: Effect of implicit solvent models, QM methods, and entropic contributions",
        "Settle: An analytical version of the SHAKE and RATTLE algorithm for rigid water models",
        "In vitro antiviral activity and resistance profile of the next-generation HCV NS3-4A protease inhibitor glecaprevir",
        "Binding mode and free energy prediction of fisetin/\u03b2-cyclodextrin inclusion complexes",
        "Screening of hepatitis C NS5B polymerase inhibitors containing benzothiadiazine core: A steered molecular dynamics",
        "Exploring protein native states and large-scale conformational changes with a modified generalized born model",
        "Resistance outside the substrate envelope: Hepatitis C NS3/4A protease inhibitors",
        "Biophysical studies on HCV 1a NS3/4A protease and its catalytic triad in wild type and mutants by the in silico approach",
        "Understanding the drug resistance mechanism of hepatitis C virus NS3/4A to ITMN-191 due to R155K, A156V, D168A/E mutations: A computational study",
        "In vitro and in vivo antiviral activity and resistance profile of the hepatitis C virus NS3/4A protease inhibitor ABT-450",
        "The molecular basis of drug resistance against hepatitis C virus NS3/4A protease inhibitors",
        "Drug resistance against HCV NS3/4A inhibitors is defined by the balance of substrate recognition versus inhibitor binding",
        "Quinoxaline-based linear HCV NS3/4A protease inhibitors exhibit potent activity against drug resistant variants",
        "Investigation of MK-5172 resistance against R155K NS3/4A protease by molecular simulation approach",
        "Accurate calculation of hydration free energies using macroscopic solvent models",
        "Hepatitis C virus drug resistance associated substitutions and their clinical relevance: Update 2018",
        "Molecular and dynamic mechanism underlying drug resistance in genotype 3 hepatitis C NS3/4A protease",
        "Structural and thermodynamic effects of macrocyclization in HCV NS3/4A inhibitor MK-5172",
        "Zinc binding in proteins and solution: A simple but accurate nonbonded representation",
        "Discovery of the pan-genotypic hepatitis C virus NS3/4A protease inhibitor voxilaprevir (GS-9857): A component of Vosevi\u00ae",
        "Molecular and structural mechanism of pan-genotypic HCV NS3/4A protease inhibition by glecaprevir",
        "Development and testing of a general Amber force field",
        "Computational study on the drug resistance mechanism against HCV NS3/4A protease inhibitors vaniprevir and MK-5172 by the combination use of molecular dynamics simulation, residue interaction network, and substrate envelope analysis",
        "Molecular modeling study on the resistance mechanism of HCV NS3/4A serine protease mutants R155K, A156V and D168A to TMC435",
        "UCSF Chimera, MODELLER, and IMP: An integrated modeling system",
        "Hepatitis C - New drugs and treatment prospects"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Maha Sarakham",
            "@id": "60002875",
            "affilname": "Mahasarakham University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002875",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nakhon Pathom",
            "@id": "60012718",
            "affilname": "Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Chulalongkorn University",
        "National Research Council of Thailand",
        "Mahasarakham University",
        "PERCH-CIC",
        "Ministry of Higher Education, Science, Research and Innovation"
    ]
}